Jones Paul A., Chief People Officer at USANA Health Sciences (USNA), has demonstrated a consistent pattern of selling activity over the past several years, with no recorded purchases in the same period. According to SEC Form 4 filings, Jones has executed 25 transactions exclusively involving USNA shares, all of which were sales or dispositions, totaling approximately $293,988 in aggregate value. The most significant single transaction occurred on May 22, 2024, when Jones sold shares worth $132,063.51. Smaller but repeated sales followed in early 2026, including dispositions of $29,030.48 on February 27, $18,608.48 on February 8, $10,157.84 on February 7, and $16,090.36 on February 6.
The filings also show a recurring pattern of transactions around February each year, likely tied to scheduled vesting events or tax planning, though the filings do not specify the exact nature of these dispositions. Notably, the "F" transaction codes indicate that many of these sales were part of planned dispositions, such as those under Rule 10b5-1 trading plans. While Jones has not acquired any shares during this period, the sales suggest a steady reduction in holdings rather than an abrupt exit. The absence of buying activity and the repeated, methodical selling over multiple years point to a deliberate strategy of gradually liquidating USNA equity.
AI-assisted summary